Patents by Inventor Michael L. Bittner
Michael L. Bittner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9255348Abstract: Exposure to ionizing radiation can produce a well-defined dose dependent signature in terms of changes in gene expression. In approaches and devices described herein, such a signature can be used to generate and use a self-contained radiation biodosimeter device, based on, for example, a blood finger stick. Various aspects of the invention are directed to biodosimetry with a fully integrated biochip using gene expression signatures.Type: GrantFiled: August 24, 2007Date of Patent: February 9, 2016Assignee: The Trustees of Columbia University in the City of New YorkInventors: Frederic Zenhausern, Christine Orozco, Mark Richards, Carl Yamashiro, Sally A. Amundson, Ralf Lenigk, Michael L. Bittner, Yoganand Balagurunathan
-
Publication number: 20100144558Abstract: Exposure to ionizing radiation can produce a well-defined dose dependent signature in terms of changes in gene expression. In approaches and devices described herein, such a signature can be used to generate and use a self-contained radiation biodosimeter device, based on, for example, a blood finger stick. Various aspects of the invention are directed to biodosimetry with a fully integrated biochip using gene expression signatures.Type: ApplicationFiled: August 24, 2007Publication date: June 10, 2010Inventors: Frederic Zenhausern, Christine Orozco, Mark Richards, Carl Yamashiro, Sally A. Amundson, Ralf Lenigk, Michael L. Bittner, Yoganand Balagurunathan
-
Patent number: 7003403Abstract: Relatedness between genes is quantified by constructing nonlinear models predicting gene expression. Effectiveness of the model is evaluated to provide a measurement of the relatedness of genes associated with the model. Various types of models, including full-logic or neural networks can be constructed. A graphical user interface presents results of the analysis to allow evaluation by a user. Each gene's contribution to the measurement of relatedness can be shown on a graph, and graphical representations of models used to predict gene expression can be displayed.Type: GrantFiled: June 15, 2000Date of Patent: February 21, 2006Assignees: The United States of America as represented by the Department of Health and Human Services, The Texas A & M University SystemInventors: Edward R. Dougherty, Seungchan Kim, Michael L. Bittner, Yidong Chen
-
Patent number: 6569626Abstract: Direct label probe compositions which stain DNA of a preselected single chromosome or region of a chromosome of a multi-chromosomal genome are provided that comprise mixed DNA segments which are covalently bound to fluorophore groups through linking groups. The mixed DNA segments are derived from the DNA present in the preselected chromosome or chromosome region. These probe compositions can be used concurrently or sequentially with other probe compositions.Type: GrantFiled: June 21, 2001Date of Patent: May 27, 2003Assignee: Vysis, Inc.Inventors: Michael L. Bittner, Larry E. Morrison, Mona S. Legator
-
Publication number: 20020025523Abstract: Direct label probe compositions which stain DNA of a preselected single chromosome or region of a chromosome of a multi-chromosomal genome are provided that comprise mixed DNA segments which are covalently bound to fluorophore groups through linking groups. The mixed DNA segments are derived from the DNA present in the preselected chromosome or chromosome region. These probe compositions can be used concurrently or sequentially with other probe compositions.Type: ApplicationFiled: June 21, 2001Publication date: February 28, 2002Inventors: Michael L. Bittner, Larry E. Morrison, Mona S. Legator
-
Patent number: 6277569Abstract: Direct label probe compositions which stain DNA of a preselected single chromosome or region of a chromosome of a multi-chromosomal genome are provided that comprise mixed DNA segments which are covalently bound to fluorophore groups through linking groups. The mixed DNA segments are derived from the DNA present in the preselected chromosome or chromosome region. These probe compositions can be used concurrently or sequentially with other probe compositions.Type: GrantFiled: July 6, 1998Date of Patent: August 21, 2001Assignee: Vysis, Inc.Inventors: Michael L. Bittner, Larry E. Morrison, Mona S. Legator
-
Patent number: 6245517Abstract: Gene expression can be quantitatively analyzed by hybridizing fluor-tagged mRNA to targets on a cDNA micro-array. Comparison of gene expression levels arising from co-hybridized samples is achieved by taking ratios of average expression levels for individual genes. In an image-processing phase, a method of image segmentation identifies cDNA target sites in a cDNA micro-array image. The resulting cDNA target sites are analyzed based on a hypothesis test and confidence interval to quantify the significance of observed differences in expression ratios. In particular, the probability density of the ratio and the maximum-likelihood estimator for the distribution are derived, and an iterative procedure for signal calibration is developed.Type: GrantFiled: September 28, 1999Date of Patent: June 12, 2001Assignee: The United States of America as represented by the Department of Health and Human ServicesInventors: Yidong Chen, Edward R. Dougherty, Michael L. Bittner
-
Patent number: 5958754Abstract: A method for bacterially producing IGF-I is disclosed in which Gram-negative bacteria are caused to express a gene consisting of a lamB or ompF signal sequence operatively joined to a DNA sequence encoding IGF-I and producing IGF-I which is secreted into the periplasmic space of the bacteria.Type: GrantFiled: May 23, 1991Date of Patent: September 28, 1999Assignee: Monsanto CompanyInventors: Edith Wong, Michael L. Bittner
-
Patent number: 5789161Abstract: Direct label probe compositions which counterstain genomic DNA are provided that comprise mixed DNA segments which are covalently bound to fluorophore groups through linking groups. The mixed DNA segments are derived from the total genomic DNA of a multi-chromosomal organism, especially man, and the segment mixture is approximately representative of such total genomic DNA. These probe compositions can be used concurrently or sequentially with other probe compositions. Instead of intercalating with DNA as in prior art chemical counterstains, these probe compositions hybridize with complementary segments that are present in the genomic DNA of a specimen.Type: GrantFiled: June 7, 1995Date of Patent: August 4, 1998Assignee: AMOCO CorporationInventors: Larry E. Morrison, Mona S. Legator, Michael L. Bittner
-
Patent number: 5776688Abstract: Direct label probe compositions which stain DNA of a preselected single chromosome or region of a chromosome of a multi-chromosomal genome are provided that comprise mixed DNA segments which are covalently bound to fluorophore groups through linking groups. The mixed DNA segments are derived from the DNA present in the preselected chromosome or chromosome region. These probe compositions can be used concurrently or sequentially with other probe compositions.Type: GrantFiled: January 10, 1997Date of Patent: July 7, 1998Assignee: Vysis, Inc.Inventors: Michael L. Bittner, Larry E. Morrison, Mona S. Legator
-
Patent number: 5663319Abstract: Direct label probe compositions which stain DNA of a preselected single chromosome or region of a chromosome of a multi-chromosomal genome are provided that comprise mixed DNA segments which are covalently bound to fluorophore groups through linking groups. The mixed DNA segments are derived from the DNA present in the preselected chromosome or chromosome region. These probe compositions can be used concurrently or sequentially with other probe compositions.Type: GrantFiled: June 7, 1995Date of Patent: September 2, 1997Assignee: Vysis, Inc.Inventors: Michael L. Bittner, Larry E. Morrison, Mona S. Legator
-
Patent number: 5652139Abstract: A method for bacterially producing IGF-I is disclosed in which Gram-negative bacteria are caused to express a gene consisting of a lamB or ompF signal sequence operatively joined to a DNA sequence encoding IGF-I and producing IGF-I which is secreted into the periplasmic space of the bacteria.Type: GrantFiled: May 31, 1995Date of Patent: July 29, 1997Assignee: Monsanto CompanyInventors: Edith Wong, Michael L. Bittner
-
Patent number: 5506350Abstract: Techniques for producing cloned DNA sequences are provided which sequences are complementary to DNA occurring in one selected region of one chromosome of a multi-chromosomal genome, such as the human genome. Such cloned DNA sequences can be labeled and formed into probes by conventional procedures, there are provided methods for making probe compositions which comprise mixed DNA segments derived from such a DNA sequence. An improved DNA sequence transamination procedure is provided utilizing trifluoroacetate chaotrope anions. With high concentrations of low complexity DNA, high levels of transamination are thereby achieved. These segments are covalently bound to fluorophore groups through linking groups that are transaminated preferably chaotropically into the segments.Type: GrantFiled: August 19, 1993Date of Patent: April 9, 1996Inventors: Michael L. Bittner, Lucy M. Stols, Clarissa F. Prorok, Kenneth A. Cruickshank
-
Patent number: 5491224Abstract: Direct label probe compositions which stain DNA of a preselected single chromosome or region of a chromosome of a multi-chromosomal genome are provided that comprise mixed DNA segments which are covalently bound to fluorophore groups through linking groups. The mixed DNA segments are derived from the DNA present in the preselected chromosome or chromosome region. These probe compositions can be used concurrently or sequentially with other probe compositions.Type: GrantFiled: April 4, 1994Date of Patent: February 13, 1996Inventors: Michael L. Bittner, Larry E. Morrison, Mona S. Legator
-
Patent number: 5489517Abstract: A method for bacterially producing IGF-I is disclosed in which Gram-negative bacteria are caused to express a gene consisting of a lamb or ompF signal sequence operatively joined to a DNA sequence encoding IGF-I and producing IGF-I which is secreted into the periplasmic space of the bacteria.Type: GrantFiled: May 23, 1991Date of Patent: February 6, 1996Assignee: Monsanto CompanyInventors: Edith Wong, Michael L. Bittner
-
Patent number: 5137817Abstract: An electrode set for electrotransformation of a host cell by electroporation, comprising: an electrically insulating substrate; and at least one pair of interdigitated electrodes which are carried by said substrate and which lie in a generally planar array, said electrodes and said substrate being adopted to carry a cell transformant and a host cell thereon, said electrodes and said host cell and said cell transformant being adapted to pass electrical current upon the application of a potential difference across said electrodes.Type: GrantFiled: October 5, 1990Date of Patent: August 11, 1992Assignee: Amoco CorporationInventors: Heinz H. Busta, Michael L. Bittner, Richard E. Cuellar
-
Patent number: 5087564Abstract: A method for obtaining heterologous peptides from fusion proteins wherein heterologous peptides include eucaryotic hormones such as atrial peptides. A novel DNA sequence encoding atrial peptide III. Various genes, DNA vectors, endopeptidases and transformed bacteria useful in practicing the method of the present invention.Type: GrantFiled: July 18, 1989Date of Patent: February 11, 1992Assignee: Monsanto CompanyInventors: Marilyn S. Mai, Michael L. Bittner, Sarah R. Braford
-
Patent number: 5084384Abstract: A method for bacterially producing IGF-I is disclosed in which Gram-negative bacteria are caused to express a gene consisting of a lamB or ompF signal sequence operatively joined to a DNA sequence encoding IGF-I and producing IGF-I which is secreted into the periplasmic space of the bacteria.Type: GrantFiled: May 10, 1990Date of Patent: January 28, 1992Assignee: Monsanto CompanyInventors: Edith Wong, Michael L. Bittner
-
Patent number: 4843006Abstract: This invention relates to the expression and accumulation in bacterial cells of heterologous polypeptides under the control of the recA promoter/operator region. One such polypeptide comprises a recA/somatostatin fusion polypeptide. This fusion polypeptide has been expressed and accumulated by E. coli with much greater effectiveness than other somatostatin-containing fusion polypeptides. In addition, use of the recA promoter/opeerator region provides greater induction flexibility than other inducible promoter systems.Type: GrantFiled: April 21, 1986Date of Patent: June 27, 1989Assignee: Monsanto CompanyInventor: Michael L. Bittner